Serum cholinesterase activities distinguish between stroke patients and controls and predict 12-month mortality

Molecular Medicine

Volumn 16, Issue 7-8, 2010, Pages 278-286

  Assayag, Einor Ben ^a   Shenhar Tsarfaty, Shani ^a,c   Ofek, Keren ^b   Soreq, Lilach ^d   Bova, Irena ^a   Shopin, Ludmila ^a   Berg, Ronan M G ^e   Berliner, Shlomo ^a,c   Shapira, Itzhak ^a,c   Bornstein, Natan M ^a,c   Soreq, Hermona ^b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^e Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; C REACTIVE PROTEIN; CHOLINESTERASE; FIBRINOGEN; INTERLEUKIN 6; ACETYLCHOLINE; AUTACOID; BIOLOGICAL MARKER;

AGED; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ENZYME ACTIVITY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; SURVIVAL RATE; ANTIBODY SPECIFICITY; BIOLOGY; BLOOD; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; DISCRIMINANT ANALYSIS; ENZYMOLOGY; GENETICS; MIDDLE AGED; PREDICTIVE VALUE; RISK FACTOR; VERY ELDERLY;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BUTYRYLCHOLINESTERASE; CASE-CONTROL STUDIES; COMPUTATIONAL BIOLOGY; DISCRIMINANT ANALYSIS; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; ORGAN SPECIFICITY; PREDICTIVE VALUE OF TESTS; RISK FACTORS; STROKE;

EID: 77954254517     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2010.00015     Document Type: Article

References (31)

1. Rosamond W, et al. (2007) Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 115: e69-171.
2. Whiteley W, Tseng MC, Sandercock P. (2008) Blood biomarkers in the diagnosis of ischemic stroke: a systematic review. Stroke. 39:2902-9.
3. McColl BW, Allan SM, Rothwell NJ. (2009) Systemic infection, inflammation and acute ischemic stroke. Neuroscience. 158:1049-61.
4. Beamer NB, Coull BM, Clark WM, Hazel JS, Silberger JR. (1995) Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann. Neurol. 37:800-5.
5. Fassbender K, et al. (1994) Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J. Neurol. Sci. 122:135-9.
6. Di Napoli M, Papa F. (2002) Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in firstever ischemic stroke patients. Stroke. 33:1763-71.
7. Elkind MS, Cheng J, Rundek T, Boden-Albala B, Sacco RL. (2004) Leukocyte count predicts outcome after ischemic stroke: the Northern Manhattan Stroke Study. J. Stroke Cerebrovasc. Dis. 13:220-7.
8. Vila N, Castillo J, Davalos A, Chamorro A. (2000) Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke. 31:2325-9.
9. Metz CN, Tracey KJ. (2005) It takes nerve to dampen inflammation. Nat. Immunol. 6:756-7.
10. Shaked I, et al. (2009). MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase. Immunity. 31:965-73.
11. cover. Accompanied by preview O'Neil, L.A.J. (2009) Boosting the brain's ability to block inflammation via microRNA-132. Immunity. 31:854-5.
12. Borovikova LV, et al. (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 405:458-62.
13. Ofek K, et al. (2007) Cholinergic status modulations in human volunteers under acute inflammation. J. Mol. Med. 85:1239-51.
14. Wang H, et al. (2003) Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature. 421:384-8.
15. Hejmadi MV, Dajas-Bailador F, Barns SM, Jones B, Wonnacott S. (2003) Neuroprotection by nicotine against hypoxia-induced apoptosis in cortical cultures involves activation of multiple nicotinic acetylcholine receptor subtypes. Mol. Cell. Neurosci. 24:779-86.
16. Fujiki M, Kobayashi H, Uchida S, Inoue R, Ishii K. (2005) Neuroprotective effect of donepezil, a nicotinic acetylcholine-receptor activator, on cerebral infarction in rats. Brain Res. 1043:236-41.
17. Kaufer D, Friedman A, Seidman S, Soreq H. (1998) Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature. 393:373-7.
18. Loewenstein-Lichtenstein Y, et al. (1995) Genetic predisposition to adverse consequences of anticholinesterases in 'atypical' BCHE carriers. Nat. Med. 1:1082-5.
19. Bartels CF, et al. (1992) DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites. Am. J. Hum. Genet. 50:1086-103.
20. Adams HP Jr, et al. (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 24:35-41.
21. Abdi H. (2007) Discriminant correspondence analysis. In: Encyclopedia of Measurement and Statistics. Salkind NJ (ed.), Rasmussen K (managing ed.) SAGE Publications, Thousand Oaks, CA, pp. 270-5.
22. McLachlan GJ. (2004) Discriminant Analysis and Statistical Pattern Recognition. Hoboken (NJ): Wiley-Interscience. 526 pp.
23. Haematology ICfSi. (1977) Recommendation of measurement of erythrocyte sedimentation rate of human blood. Am. J. Clin. Pathol. 68:505-7.
24. Rifai N, Tracy RP, Ridker PM. (1999) Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin. Chem. 45:2136-41.
25. Clauss A. (1957) Rapid physiological coagulation method in determination of fibrinogen [in German]. Acta. Haematol. 17:237-46.
26. Sklan EH, et al. (2004) Acetylcholinesterase/ paraoxonase genotype and expression predict anxiety scores in Health, Risk Factors, Exercise Training, and Genetics study. Proc. Natl. Acad. Sci. U. S. A. 101:5512-7.
27. Hetherington KA, Losek JD. (2005) Myasthenia gravis: myasthenia vs. cholinergic crisis. Pediatr. Emerg. Care. 21:546-8; quiz 549-51. Review.
28. Barker-Collo SL. (2007) Depression and anxiety 3 months post stroke: prevalence and correlates. Arch. Clin. Neuropsychol. 22:519-31.
29. Nassar BA, et al. (2002) Relation between butyrylcholinesterase K variant, paraoxonase 1 (PON1) Q and R and apolipoprotein E epsilon 4 genes in earlyonset coronary artery disease. Clin. Biochem. 35:205-9.
30. Duysen EG, Li B, Lockridge O. (2009) The butyrylcholinesterase knockout mouse a research tool in the study of drug sensitivity, bio-distribution, obesity and Alzheimer's disease. Expert Opin. Drug Metab. Toxicol. 5:523-8.
31. Jerrard-Dunne P, et al. (2004) Inflammatory gene load is associated with enhanced inflammation and early carotid atherosclerosis in smokers. Stroke. 35:2438-43.